Arabic Arabic English English French French German German
dark

Guidelines for the inclusion of pathology in clinical trial protocols: SPIRIT-Path

An international group of cancer researchers, led by the National Cancer Research Institute’s (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance to address the variability in how pathology is planned and delivered in clinical trials. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Nasal microbiota holds clues to who will develop symptoms from SARS-CoV-2

Next Post

Anti-seizure medication improves cognitive function in some Alzheimer’s patients

Related Posts
Total
0
Share